Results 121 to 130 of about 70,663 (209)

Chimeric antigen receptor (CAR) T-cell therapy for glioblastoma (GBM): current clinical insights, challenges, and future directions. [PDF]

J Immunother Cancer
Walton CM, Bell M, O'Neil R, Sahin O, Choi BD, Fecci PE, Strickland BA.   +6 more
europepmc   +1 more source

A universal chimeric antigen receptor (CAR)-fragment antibody binder (FAB) split system for cancer immunotherapy. [PDF]

Sci Adv
Arina A, Arauz E, Masoumi E, Warzecha KW, Sääf A, Widło Ł, Slezak T, Zieminska A, Dudek K, Schaefer ZP, Lecka M, Usatyuk S, Weichselbaum RR, Kossiakoff AA.   +13 more
europepmc   +1 more source

Sex Differences in Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy. [PDF]

Cancer Med
Tan JY, Yeo YH, Kin HWK, Ang QX, Chisti MM, Ezekwudo D, Hilal T.   +6 more
europepmc   +1 more source

Chimeric antigen receptors (CARs) that require dual-antigen binding for activation [PDF]

Science-Business eXchange, 2013
openaire   +1 more source

Predictors of Neurotoxicity in a Large Cohort of Italian Patients Undergoing Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy. [PDF]

Brain Behav
Modoni A, Vollono C, Galli E, Capriati L, Sorà F, Hohaus S, Servidei S, Piccirillo N, Calabresi P, Sica S.   +9 more
europepmc   +1 more source

Construction, expression, and characterization of rSEA-EGF and in vitro evaluation of its antitumor activity against nasopharyngeal cancer [PDF]

, 2018
He, Ying, Liu, Xueting, Tao, Ailin, Wang, Shan, Xie, Yang, Zeng, Liping, Zhang, Jianguo, Zhang, Junyan, Zhou, Zhongqiu, Zou, Zehong   +9 more
core   +2 more sources

Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer. [PDF]

Nat Commun
Chang K, Delavan HM, Yip E, Kasap C, Zhu J, Lodha R, Liao SY, Berman SC, Carretero-Gonzalez A, Basar M, Gokturk Ozcan G, Teo MY, Solit DB, Rosenberg JE, Al-Ahmadie H, Ding CCK, Chan E, Steri V, Porten SP, Koshkin VS, Friedlander TW, Feng FY, Lee JK, Wiita AP, Chu CE, Chou J.   +25 more
europepmc   +1 more source

Targeting TGFβ docking receptor glycoprotein A repetitions predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat glioblastoma. [PDF]

Neuro Oncol
Wu BX, Kreatsoulas D, Cam H, Bolyard C, Chang Y, Mandula J, Welsh PW, Wang Z, Li A, Weltge P, Reynolds K, Amankwah Y, Elder JB, Giglio P, Otero JJ, Rajappa P, Gerald D, Chung D, Ma Q, Velegraki M, Li Z.   +20 more
europepmc   +1 more source

Impact of cellular composition and T-cell senescence of mononuclear cell concentrates on the manufacturing process of chimeric antigen receptor (CAR) T-cells. [PDF]

Transfusion
Vučinić V, Tumewu T, Brückner M, Kirchberg J, Jentzsch M, Buhmann R, Remane Y, Hoffmann S, Ramdohr F, Merz M, Metzeler KH, Schwind S, Herling C, Krauß SM, Herling M, Franke GN, Grieb N, Stachel G, Janz M, Penack O, Bullinger L, Keller U, Cross M, Henschler R, Bach E, Platzbecker U.   +25 more
europepmc   +1 more source

Precision-cut tumor tissue slices, a novel tool to study the tumor microenvironment interactions with chimeric antigen receptor (CAR) T cells. [PDF]

PLoS One
Durante V, Wittwer A, Theek B, Martinez-Osuna M, Donnadieu E, Hardt O, Eckardt D, Bosio A, Schallenberg S, Herbel C.   +9 more
europepmc   +1 more source